TREACE MEDICAL CONCEPTS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Treace Medical Concepts, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Treace Medical Concepts, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.9M, a 52.2% increase year-over-year.
  • Treace Medical Concepts, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $27.9M, a 100% increase year-over-year.
  • Treace Medical Concepts, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.4M, a 114% increase from 2022.
  • Treace Medical Concepts, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.11M, a 138% increase from 2021.
  • Treace Medical Concepts, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.41M, a 271% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $27.9M $7.9M +$2.71M +52.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $25.2M $6.74M +$3.14M +87.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $22.1M $7.41M +$4.72M +175% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $17.4M $5.87M +$3.4M +138% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $14M $5.19M +$2.92M +129% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $11M $3.6M +$1.63M +83.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $9.39M $2.69M +$1.28M +91.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $8.11M $2.47M +$1.18M +91% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $6.93M $2.27M +$1.43M +170% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.5M $1.96M +$1.09M +124% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.42M $1.41M +$1.01M +250% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.41M $1.29M +$956K +284% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $2.45M $839K +$714K +571% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.74M $875K +$627K +253% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.11M $402K +$193K +92.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $919K $337K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-08
Q3 2020 $125K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $248K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $209K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.